Douglas A. Treco - Insider Trading & Ownership

Entity
Individual
Location
87 Cambridgepark Drive, C/O Ra Pharmaceuticals, Inc., Cambridge, MA
Summary
The estimated net worth of Douglas A. Treco is at least $349K dollars as of October 3, 2024. Douglas A. Treco is the CEO, Director of Inozyme Pharma, Inc. and owns shares of Inozyme Pharma, Inc. (INZY) stock worth about $349K.
All Insider Reports
All Insider Reports

Ownership of Douglas A. Treco

Insider Transactions Reported by Douglas A. Treco:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.